Works matching AU Dreyling, Martin

Results: 157
    1
    2
    3

    Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial.

    Published in:
    International Journal of Hematology, 2023, v. 117, n. 2, p. 251, doi. 10.1007/s12185-022-03481-y
    By:
    • Fukuhara, Noriko;
    • Kato, Koji;
    • Goto, Hideki;
    • Takeshi, Tajima;
    • Kawaguchi, Mayu;
    • Tokushige, Kota;
    • Akashi, Koichi;
    • Teshima, Takanori;
    • Harigae, Hideo;
    • Schuster, Stephen J.;
    • Thieblemont, Catherine;
    • Dreyling, Martin;
    • Fowler, Nathan
    Publication type:
    Article
    4
    5

    Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.

    Published in:
    2019
    By:
    • König, Laila;
    • Dreyling, Martin;
    • Dürig, Jan;
    • Engelhard, Marianne;
    • Hohloch, Karin;
    • Viardot, Andreas;
    • Witzens-Harig, Mathias;
    • Kieser, Meinhard;
    • Klapper, Wolfram;
    • Pott, Christiane;
    • Herfarth, Klaus
    Publication type:
    journal article
    6

    Antikörpertherapie maligner Lymphome.

    Published in:
    Medizinische Klinik (Urban & Vogel), 2005, v. 100, n. 1, p. 14, doi. 10.1007/s00063-005-1115-0
    By:
    • Buske, Christian;
    • Dreyling, Martin;
    • Unterhalt, Michael;
    • Hiddemann, Wolfgang
    Publication type:
    Article
    7

    The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
    By:
    • Rejeski, Kai;
    • Wang, Yucai;
    • Albanyan, Omar;
    • Munoz, Javier;
    • Sesques, Pierre;
    • Iacoboni, Gloria;
    • Lopez‐Corral, Lucia;
    • Ries, Isabelle;
    • Bücklein, Veit L.;
    • Mohty, Razan;
    • Dreyling, Martin;
    • Baluch, Aliyah;
    • Shah, Bijal;
    • Locke, Frederick L.;
    • Hess, Georg;
    • Barba, Pere;
    • Bachy, Emmanuel;
    • Lin, Yi;
    • Subklewe, Marion;
    • Jain, Michael D.
    Publication type:
    Article
    8

    Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 4, p. 362, doi. 10.1002/ajh.25711
    By:
    • Dreyling, Martin;
    • Santoro, Armando;
    • Mollica, Luigina;
    • Leppä, Sirpa;
    • Follows, George;
    • Lenz, Georg;
    • Won Seog Kim;
    • Nagler, Arnon;
    • Dimou, Maria;
    • Demeter, Judit;
    • Özcan, Muhit;
    • Kosinova, Marina;
    • Bouabdallah, Krimo;
    • Morschhauser, Franck;
    • Stevens, Don A.;
    • Trevarthen, David;
    • Munoz, Javier;
    • Rodrigues, Liana;
    • Hiemeyer, Florian;
    • Miriyala, Ashok
    Publication type:
    Article
    9
    10
    11
    12
    13

    Are Biosimilars the Future of Oncology and Haematology?

    Published in:
    Drugs, 2019, v. 79, n. 15, p. 1609, doi. 10.1007/s40265-019-01193-y
    By:
    • Zinzani, Pier Luigi;
    • Dreyling, Martin;
    • Gradishar, William;
    • Andre, Marc;
    • Esteva, Francisco J.;
    • Boulos, Suliman;
    • González Barca, Eva;
    • Curigliano, Giuseppe
    Publication type:
    Article
    14
    15

    Current Management of Mantle Cell Lymphoma.

    Published in:
    Drugs, 2007, v. 67, n. 12, p. 1689, doi. 10.2165/00003495-200767120-00004
    By:
    • Weigert, Oliver;
    • Unterhalt, Michael;
    • Hiddemann, Wolfgang;
    • Dreyling, Martin
    Publication type:
    Article
    16
    17

    Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 12, p. 2226, doi. 10.3109/10428194.2011.600488
    By:
    • Dreyling, Martin;
    • Kluin-Nelemans, Hanneke C.;
    • Beà, Sílvia;
    • Hartmann, Elena;
    • Salaverria, Itziar;
    • Hutter, Grit;
    • Perez-Galan, Patricia;
    • Roue, Gael;
    • Pott, Christiane;
    • Gouill, Steven Le;
    • Cortelazzo, Sergio;
    • Rule, Simon;
    • Hess, Georg;
    • Zaja, Francesco;
    • Vitolo, Umberto;
    • Szymczyk, Michal;
    • Walewski, Jan;
    • Ribrag, Vincent;
    • Unterhalt, Michael;
    • Hermine, Olivier
    Publication type:
    Article
    18
    19
    20

    Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 9, p. 1612, doi. 10.3109/10428194.2010.496507
    By:
    • Dreyling, Martin;
    • Hoster, Eva;
    • Bea, Silvia;
    • Hartmann, Elena;
    • Horn, Heike;
    • Hutter, Grit;
    • Salaverria, Itziar;
    • Pott, Christiane;
    • Trneny, Marek;
    • Le Gouill, Steven;
    • Cortelazzo, Sergio;
    • Szymczyk, Michal;
    • Jurczak, Wojciech;
    • Shpilberg, Ofer;
    • Ribrag, Vincent;
    • Hermine, Olivier
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29

    High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).

    Published in:
    Leukemia & Lymphoma, 2007, v. 48, n. 7, p. 1299, doi. 10.1080/10428190701361828
    By:
    • Weide, Rudolf;
    • Hess, Georg;
    • Köppler, Hubert;
    • Heymanns, Jochen;
    • Thomalla, Jörg;
    • Aldaoud, Ali;
    • Losem, Christoph;
    • Schmitz, Stefan;
    • Haak, Ursula;
    • Huber, Christoph;
    • Unterhalt, Michael;
    • Hiddemann, Wolfgang;
    • Dreyling, Martin
    Publication type:
    Article
    30

    Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2020, v. 477, n. 2, p. 259, doi. 10.1007/s00428-020-02750-7
    By:
    • Croci, Giorgio A.;
    • Hoster, Eva;
    • Beà, Sílvia;
    • Clot, Guillem;
    • Enjuanes, Anna;
    • Scott, David W.;
    • Cabeçadas, José;
    • Veloza, Luis;
    • Campo, Elias;
    • Clasen-Linde, Erik;
    • Goswami, Rashmi S.;
    • Helgeland, Lars;
    • Pileri, Stefano;
    • Rymkiewicz, Grzegorz;
    • Reinke, Sarah;
    • Dreyling, Martin;
    • Klapper, Wolfram
    Publication type:
    Article
    31
    32
    33

    Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up.

    Published in:
    HemaSphere, 2024, v. 8, n. 6, p. 1, doi. 10.1002/hem3.89
    By:
    • Ferreri, Andreas J. M.;
    • Illerhaus, Gerald;
    • Doorduijn, Jeanette K.;
    • Auer, Dorothee P.;
    • Bromberg, Jacoline E. C.;
    • Calimeri, Teresa;
    • Cwynarski, Kate;
    • Fox, Christopher P.;
    • Hoang‐Xuan, Khê;
    • Malaise, Denis;
    • Ponzoni, Maurilio;
    • Schorb, Elisabeth;
    • Soussain, Carole;
    • Specht, Lena;
    • Zucca, Emanuele;
    • Buske, Christian;
    • Jerkeman, Mats;
    • Dreyling, Martin
    Publication type:
    Article
    34
    35

    PB2304: FIVE‐YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L‐MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000975944.73895.05
    By:
    • Duell, Johannes;
    • Abrisqueta, Pau;
    • Dreyling, Martin;
    • Gaidano, Gianluca;
    • Barca, Eva González;
    • Jurczak, Wojciech;
    • Liberati, Anna Marina;
    • Maddocks, Kami;
    • Menne, Tobias;
    • Nagy, Zsolt;
    • Tournilhac, Olivier;
    • Bakuli, Abhishek;
    • Amin, Aasim;
    • Gurbanov, Konstantin;
    • Salles, Gilles
    Publication type:
    Article
    36

    Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study.

    Published in:
    HemaSphere, 2023, v. 7, n. 7, p. e919, doi. 10.1097/HS9.0000000000000919
    By:
    • Townsend, William;
    • Hiddemann, Wolfgang;
    • Buske, Christian;
    • Cartron, Guillaume;
    • Cunningham, David;
    • Dyer, Martin J.S.;
    • Gribben, John G.;
    • Phillips, Elizabeth H.;
    • Dreyling, Martin;
    • Seymour, John F.;
    • Grigg, Andrew;
    • Trotman, Judith;
    • Lin, Tong‐Yu;
    • Hong, Xiao‐Nan;
    • Kingbiel, Dirk;
    • Nielsen, Tina G.;
    • Knapp, Andrea;
    • Herold, Michael;
    • Marcus, Robert
    Publication type:
    Article
    37
    38

    Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR‐T for Relapsed/Refractory B‐NHL.

    Published in:
    HemaSphere, 2023, v. 7, n. 4, p. e858, doi. 10.1097/HS9.0000000000000858
    By:
    • Rejeski, Kai;
    • Blumenberg, Viktoria;
    • Iacoboni, Gloria;
    • Lopez‐Corral, Lucia;
    • Kharboutli, Soraya;
    • Hernani, Rafael;
    • Petrera, Agnese;
    • Müller, Niklas;
    • Hildebrand, Friederike;
    • Frölich, Lisa;
    • Karschnia, Philipp;
    • Schmidt, Christian;
    • Cordas dos Santos, David M.;
    • Piñana, José Luis;
    • Müller, Fabian;
    • Martin, Ana Africa;
    • Dreyling, Martin;
    • von Bergwelt‐Baildon, Michael;
    • Barba, Pere;
    • Subklewe, Marion
    Publication type:
    Article
    39

    A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.

    Published in:
    HemaSphere, 2023, v. 7, n. 3, p. e842, doi. 10.1097/HS9.0000000000000842
    By:
    • El‐Galaly, Tarec Christoffer;
    • Gaidzik, Verena I.;
    • Gaman, Mihnea‐Alexandru;
    • Antic, Darko;
    • Okosun, Jessica;
    • Copland, Mhairi;
    • Sexl, Veronika;
    • Fielding, Adele K.;
    • Doeswijk, Robin;
    • Parker, Helen;
    • Dreyling, Martin;
    • Döhner, Konstanze;
    • Almeida, António Medina;
    • Macintyre, Elizabeth;
    • Gribben, John G.;
    • Grønbæk, Kirsten
    Publication type:
    Article
    40

    First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial.

    Published in:
    HemaSphere, 2022, v. 6, n. 12, p. e808, doi. 10.1097/HS9.0000000000000808
    By:
    • Braulke, Friederike;
    • Zettl, Florian;
    • Ziepert, Marita;
    • Viardot, Andreas;
    • Kahl, Christoph;
    • Prange-Krex, Gabriele;
    • Korfel, Agnieszka;
    • Dreyling, Martin;
    • Bott, Alexander;
    • Wedding, Ulrich;
    • Reichert, Dietmar;
    • de Wit, Maike;
    • Hartmann, Frank;
    • Poeschel, Viola;
    • Schmitz, Norbert;
    • Witzens-Harig, Mathias;
    • Klapper, Wolfram;
    • Rosenwald, Andreas;
    • Wulf, Gerald;
    • Altmann, Bettina
    Publication type:
    Article
    41

    Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.

    Published in:
    HemaSphere, 2022, v. 6, n. 9, p. e767, doi. 10.1097/HS9.0000000000000767
    By:
    • Horn, Heike;
    • Jurinovic, Vindi;
    • Leich, Ellen;
    • Kalmbach, Sabrina;
    • Bausinger, Julia;
    • Staiger, Annette M.;
    • Kurz, Katrin S.;
    • Moller, Peter;
    • Bernd, Heinz-Wolfram;
    • Feller, Alfred C.;
    • Koch, Karoline;
    • Klapper, Wolfram;
    • Stein, Harald;
    • Hansmann, Martin-Leo;
    • Hartmann, Sylvia;
    • Scheubeck, Gabriel;
    • Dreyling, Martin;
    • Hiddemann, Wolfgang;
    • Herfarth, Klaus;
    • Engelhard, Marianne
    Publication type:
    Article
    42
    43

    The EHA Research Roadmap: Malignant Lymphoid Diseases.

    Published in:
    HemaSphere, 2022, v. 6, n. 6, p. e726, doi. 10.1097/HS9.0000000000000726
    By:
    • Dreyling, Martin;
    • André, Marc;
    • Gökbuget, Nicola;
    • Tilly, Hervé;
    • Jerkeman, Mats;
    • Gribben, John;
    • Ferreri, Andrés;
    • Morel, Pierre;
    • Stilgenbauer, Stephan;
    • Fox, Christopher;
    • Maria Ribera, José;
    • Zweegman, Sonja;
    • Aurer, Igor;
    • Bödör, Csaba;
    • Burkhardt, Birgit;
    • Buske, Christian;
    • Dollores Caballero, Maria;
    • Campo, Elias;
    • Chapuy, Bjoern;
    • Davies, Andrew
    Publication type:
    Article
    44
    45
    46

    Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T‐cell Lymphoma.

    Published in:
    HemaSphere, 2022, v. 6, n. 2, p. e672, doi. 10.1097/HS9.0000000000000672
    By:
    • Houot, Roch;
    • Poeschel, Viola;
    • Altmann, Bettina;
    • Angel, Stephanie;
    • Thurner, Lorenz;
    • Illmer, Thomas;
    • Andre, Marc;
    • Dreyling, Martin;
    • Maisonneuve, Hervé;
    • Tilly, Hervé;
    • Mayer, Stephanie;
    • Casasnovas, Olivier;
    • Le Gouill, Steven;
    • Offner, Fritz;
    • Cartron, Guillaume;
    • Kerkhoff, Andrea;
    • Weber, Thomas;
    • Hoffmann, Joerg;
    • Ziepert, Marita;
    • Klapper, Wolfram
    Publication type:
    Article
    47
    48

    Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 1, p. 14, doi. 10.1080/10428194.2023.2268228
    By:
    • Hess, Georg;
    • Dreyling, Martin;
    • Oberic, Lucie;
    • Gine, Eva;
    • Zinzani, Pier Luigi;
    • Linton, Kim;
    • Vilmar, Adam;
    • Jerkeman, Mats;
    • Chen, Jenny M. H.;
    • Ohler, Anke;
    • Stilgenbauer, Stephan;
    • Thieblemont, Catherine;
    • Lambert, Jonathan;
    • Zilioli, Vittorio Ruggero;
    • Sancho, Juan-Manuel;
    • Jimenez-Ubieto, Ana;
    • Fischer, Luca;
    • Eyre, Toby A.;
    • Keeping, Sam;
    • Park, Julie E.
    Publication type:
    Article
    49
    50